首页 | 本学科首页   官方微博 | 高级检索  
     

曲美他嗪对急性肝衰竭小鼠肝组织NOX2和NOX4表达的影响
引用本文:汪娅,罗婷婷,李璨,赵文静,陆爽. 曲美他嗪对急性肝衰竭小鼠肝组织NOX2和NOX4表达的影响[J]. 实用肝脏病杂志, 2021, 24(6): 799-802. DOI: 10.3969/j.issn.1672-5069.2021.06.008
作者姓名:汪娅  罗婷婷  李璨  赵文静  陆爽
作者单位:550000 贵阳市 贵州医科大学(汪娅);附属医院感染病科(罗婷婷,李璨,赵文静,陆爽)
摘    要:目的 探讨曲美他嗪对急性肝衰竭小鼠肝组织NOX2和NOX4表达的影响。方法 随机将65只C57BL/6小鼠分为对照组、模型组、小、中、大剂量曲美他嗪处理组和还原型谷胱甘肽处理组,除模型组15只外,其他组均为10只。采用D-氨基半乳糖联合脂多糖腹腔注射建立急性肝衰竭模型。取肝组织匀浆检测丙二醛(MDA)和过氧化物酶(CAT)含量,采用RT-PCR法和Western blot法分别检测肝组织还原型烟酰胺腺嘌呤二核苷酸磷酸氧化酶( NOX2/4) mRNA水平和蛋白表达。结果 模型组血清ALT、AST和肝匀浆MDA水平分别为(121.4±3.7)U/L、(208.9±27.4)U/L和(51.0±20.5)nmol/mg,均显著高于对照组【分别为(35.3±3.2)U/L、(49.9±4.4)U/L和(14.1±5.2)nmol/mg,P<0.05】,而模型组肝匀浆CAT水平为(51.7±16.8)U/mg,显著低于对照组【(110.2±33.7)U/mg,P<0.05】;模型组NOX2/4 mRNA和蛋白相对水平分别为(8.2±2.0)/(1.2±0.1)和(2.6±0.1)/(1.3±0.1),均显著高于对照组【分别为(1.0±0.2)/(0.5±0.1)和(1.0±0.1)/(0.4±0.1),P<0.05】,中、大剂量曲美他嗪处理组血清ALT和AST及肝匀浆MDA水平分别为(86.4±1.00)U/L、(154.0±6.2)U/L和(22.5±1.9)nmol/mg及(81.1±1.5)U/L、(134.7±5.3)U/L和(20.1±3.7)nmol/mg,均显著低于模型组【分别为(121.4±3.7)U/L、(208.9±27.4)U/L和(51.0±20.5)nmol/mg,P<0.05】,肝匀浆CAT水平分别为(99.4±15.5)和(102.3±15.5),均显著高于模型组【(51.6±16.8),P<0.05】;肝组织NOX2/4 mRNA及蛋白相对表达量分别为(5.6±0.2)/(0.7±0.0)和(5.2±1.4/0.6±0.1)及(1.7±0.2)/(0.7±0.2)和(1.5±0.1)/(0.6±0.2),均显著低于模型组【(8.2±2.0)/(1.2±0.1)和(2.6±0.1)/(1.3±0.1),P<0.05】。结论 曲美他嗪可能通过下调肝组织NOX2/4表达减轻氧化应激损伤,改善D-Galn/LPS诱导的急性肝衰竭小鼠肝损伤。

关 键 词:急性肝衰竭  曲美他嗪  氧化应激  还原型烟酰胺腺嘌呤二核苷酸磷酸氧化酶2/4  小鼠  
收稿时间:2020-11-25

Effects of trimetazidine on the expression of NOX2 and NOX4 in liver tissues of mice with acute liver failure
Wang Ya,Luo Tingting,Li Can,et al. Effects of trimetazidine on the expression of NOX2 and NOX4 in liver tissues of mice with acute liver failure[J]. Journal of Clinical Hepatology, 2021, 24(6): 799-802. DOI: 10.3969/j.issn.1672-5069.2021.06.008
Authors:Wang Ya  Luo Tingting  Li Can  et al
Affiliation:Department of Infectious Diseases, Affiliated Hospital, Guizhou Medical University, Guiyang 550000, Guizhou Province, China
Abstract:Objective The aim of this experiment was to investigate the effect of trimetazidine on the expression of NOX2 and NOX4 in liver tissues of mice with D-Galn/LPS-induced acute liver failure (ALF). Methods 65 male C57BL/6 mice were randomly divided into control, model, low-, moderate- and high-dose of trimetazidine, as wells as reduced glutathione-intervened group, 10 in each except for those (n=15) in the model. The ALF model was established by D-Galn/LPS intraperitoneal injection. The liver tissue homogenate malondialdehyde (MDA) and peroxidase (CAT) levels were detected, and hepatic NOX2/4 mRNA levels and protein expression were assayed by RT-PCR and Western blot. Results Serum ALT, AST and hepatic MDA levels in model group were (121.4±3.7)U/L,(208.9±27.4)U/L and (51.0±20.5)nmol/mg, all significantly higher than [(35.3±3.2)U/L, (49.9±4.4)U/L and (14.1±5.2) nmol/mg, P<0.05] in the control, while hepatic CAT level was (51.7±16.8)U/mg, significantly lower than [(110.2±33.7)U/mg, P<0.05] in the control; the hepatic NOX2/4 mRNA level and their protein expression in the model were (8.2±2.0)/(1.2±0.1) and (2.6±0.1)/(1.3±0.1), significantly higher than [(1.0±0.2)/(0.5±0.1) and (1.0±0.1)/(0.4±0.1), P<0.05] in the control, serum ALT, AST and hepatic MDA levels in moderate- and high-dose trimetazidine-intervened groups were (86.4±1.00)U/L, (154.0±6.2)U/L and (22.5±1.9)nmol/mg, as well as (81.1±1.5)U/L, (134.7±5.3)U/L and (20.1±3.7)nmol/mg, significantly lower than [(121.4±3.7)U/L, (208.9±27.4)U/L and (51.0±20.5) nmol/mg, P<0.05] in the model, hepatic CAT level were (99.4±15.5) and (102.3±15.5), significantly higher than [(51.6±16.8), P<0.05] in the model; hepatic NOX2/4 mRNA levels and their protein expression were (5.6±0.2)/(0.7±0.0) and (5.2±1.4/0.6±0.1) as well as (1.7±0.2)/(0.7±0.2) and (1.5±0.1)/(0.6±0.2), significantly lower than [(8.2±2.0)/(1.2±0.1) and (2.6±0.1)/(1.3±0.1), P<0.05] in the model. Conclusion Trimetazidine might inhibit the oxidative stress by down-regulation of hepatic NOX2/4 expression and improve the liver functions in D-Galn/LPS-induced mice.
Keywords:Acute liver failure  Trimetazidine  Oxidative stress  NOX2  NOX4  Mice  
点击此处可从《实用肝脏病杂志》浏览原始摘要信息
点击此处可从《实用肝脏病杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号